BIOMAT Database Logo BIOMAT Database Logo

Effect of synthetic protease inhibitors on superoxide (O2-), hydrogen peroxide (H2O2) and hydroxyl radical production by human polymorphonuclear leukocytes. 1992

K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

The effects of clinically used protease inhibitors (aprotinin, nafamostat mesilate, gabexate mesilate) on the production of oxygen-derived free radicals (O2-, H2O2, .OH) by human polymorphonuclear leukocytes were examined. Nafamostat mesilate and gabexate mesilate markedly and dose-dependently inhibited zymosan-stimulated O2- production by human polymorphonuclear leukocytes. However, aprotinin had a slight scavenging effect on O2- produced by the xanthine-xanthine oxidase system. All the protease inhibitors inhibited H2O2 production, but had no significant scavenging effect on H2O2. Nafamostat mesilate and gabexate mesilate slightly inhibited .OH production. These results indicate that the synthetic protease inhibitors nafamostat mesilate and gabexate mesilate inhibit the production of various activated oxygen radicals by human polymorphonuclear leukocytes, and the differences in their inhibitory effects suggest that each synthetic protease inhibitor is specific for a particular oxygen-derived free radical.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D006878 Hydroxides Inorganic compounds that contain the OH- group.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion
D017665 Hydroxyl Radical The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.

Related Publications

K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
[Superoxide anion (O2-) production by polymorphonuclear leukocytes in diabetics].
June 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
The influence of electrical cardioversion on superoxide anions (O2-) production by polymorphonuclear neutrophils, hydrogen peroxide (H2O2) plasma level and malondialdehyde serum concentration.
October 1996, International journal of cardiology,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase.
October 1983, Cancer research,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Chymotrypsin-specific protease inhibitors decrease H2O2 formation by activated human polymorphonuclear leukocytes.
September 1987, Carcinogenesis,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide.
July 1990, Proceedings of the National Academy of Sciences of the United States of America,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Hydrogen peroxide production and killing of Staphylococcus aureus by human polymorphonuclear leukocytes.
March 1977, Blood,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Effect of corticosteroids on the production of superoxide and hydrogen peroxide and the appearance of chemiluminescence by phagocytosing polymorphonuclear leukocytes.
March 1981, Inflammation,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Effect of Haemophilus somnus on phagocytosis and hydrogen peroxide production by bovine polymorphonuclear leukocytes.
September 1992, Microbial pathogenesis,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Serine protease inhibitors inhibit superoxide production by human polymorphonuclear leukocytes and monocytes stimulated by various surface active agents.
November 1979, FEBS letters,
K Tamura, and T Manabe, and K Imanishi, and A Nonaka, and N Asano, and K Yamaki, and T Tobe
Formation of superoxide anions and hydrogen peroxide by polymorphonuclear leukocytes stimulated with cytochalasin.
January 1982, Advances in experimental medicine and biology,
Copied contents to your clipboard!